Clindex

EvidentIQ, LLC, established in 1997, is a pioneering leader in the field of clinical trial software, particularly known for its flagship product, Clindex®. This comprehensive and flexible integrated system is tailored specifically for the intricacies of medical device trials, but its capabilities extend to pharmaceutical, diagnostic, and combination product studies as well. Clindex® has earned its reputation by supporting hundreds of studies, successfully aiding in marketing applications to the FDA without any noted deficiencies during audits.

EvidentIQ's extensive service offerings include implementation, database development, and full Application Service Provider (ASP) services through a SaaS model. They cater to a diverse clientele, from Fortune 500 corporations to emerging startups, reinforcing the system's scalability and adaptability. Their commitment to customer support ensures swift resolution of challenges, which has garnered positive feedback from various industry professionals. With a global reach and a dedication to innovation, EvidentIQ is positioned as a critical partner in advancing clinical research excellence for organizations and patients alike.